The global Gastrointestinal Therapeutics Market was valued at USD 64.82 billion in 2024 and is projected to expand at a CAGR of 5.8% from 2025 to 2032. Market growth is supported by the increasing prevalence of gastrointestinal disorders, rising aging populations, broader access to prescription treatments, and continuous development of targeted drug classes that improve disease management and...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt